Does Anthem Cover Trulicity? A Complete Insurance Guide

What Is Trulicity and Why Does Insurance Coverage Matter?

Trulicity is the brand name for dulaglutide, a once-weekly injectable glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA in 2014 for glycemic control in adults with type 2 diabetes. The FDA expanded its label in 2020 to include cardiovascular risk reduction in adults with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors, based on data from the REWIND trial. 1

The list price of Trulicity sits around $900, $1,000 per month without insurance. That price point makes insurance coverage not optional for most patients, it is the difference between a sustainable therapy and one that gets abandoned within 90 days.

Why GLP-1 Coverage Is Complicated

GLP-1 receptor agonists occupy an unusual position in pharmacy benefits. They are used for type 2 diabetes, weight management, and cardiovascular risk reduction, sometimes all three in the same patient. Anthem (like most large insurers) maintains separate formulary tiers for diabetes-indicated GLP-1s versus obesity-indicated GLP-1s. Trulicity carries only a diabetes indication, so it is generally evaluated under the diabetes formulary rather than the more restrictive weight-management benefit.

The American Diabetes Association 2024 Standards of Care recommend GLP-1 receptor agonists as preferred add-on agents after metformin in patients with established atherosclerotic cardiovascular disease, heart failure, or chronic kidney disease. 2 That clinical endorsement matters when you submit a prior authorization, because it gives your prescriber a guideline-backed rationale.

Trulicity vs. Other GLP-1s on Anthem Formularies

Anthem formularies vary by state affiliate (Anthem Blue Cross CA, Anthem BCBS GA, Elevance Health plans, etc.). Where Trulicity appears on your formulary, you will often also see:

• Ozempic (semaglutide 0.5 to 2 mg weekly), frequently on Tier 2 or preferred Tier 3
• Victoza (liraglutide 1.2 to 1.8 mg daily), sometimes preferred over Trulicity
• Bydureon BCise (exenatide extended-release), occasionally on a lower cost-share tier

Anthem sometimes designates one GLP-1 as a "preferred" agent within the class, placing others on a non-preferred tier. Step therapy requirements may force a trial of the preferred agent before Trulicity is authorized. 3

How Anthem's Formulary Tiers Work for Trulicity

Anthem uses a tiered formulary structure. Most commercial plans have four to six tiers. Trulicity lands on Tier 2 (preferred brand) or Tier 3 (non-preferred brand) on the majority of Anthem commercial plans reviewed for this article.

Tier 2 Coverage

On Tier 2, typical cost-sharing after the deductible is met runs $50, $150 per 30-day supply. Some plans have a separate deductible for brand drugs, which means the first several fills could be at full negotiated cost even after the medical deductible is met.

Tier 3 Coverage

Tier 3 placement pushes cost-sharing to $150, $600 per month after deductible. Plans with coinsurance (e.g., 30% of negotiated price) rather than a flat copay can push costs higher than that estimate if the negotiated rate remains above $700/month.

Medicare Advantage and Part D Plans

On Anthem Medicare Advantage and Part D standalone plans, Trulicity typically appears on Tier 3 or Tier 4. The 2024 Medicare Part D redesign capped out-of-pocket drug costs at $3,500 in the initial coverage phase and introduced a $2,000 annual cap beginning in 2025 under the Inflation Reduction Act. 4 That cap substantially changes the math for seniors on high-cost injectable medications.

Medicaid Managed Care via Anthem

Anthem administers Medicaid managed care contracts in multiple states. Medicaid formularies are state-specific and frequently require prior authorization for brand GLP-1s. Patients with Medicaid coverage should call Anthem member services (number on the back of the card) and ask the pharmacy to run a test claim before assuming coverage.

Prior Authorization Requirements for Trulicity on Anthem Plans

Prior authorization (PA) is required for Trulicity on nearly every Anthem commercial, Medicare Advantage, and Medicaid plan. The PA process is not a denial. It is a clinical review step. Approval rates are higher when the prescriber submits complete documentation on the first attempt.

Typical PA Criteria Anthem Uses

Standard PA criteria for Trulicity on Anthem commercial plans include:

1. Confirmed diagnosis of type 2 diabetes (ICD-10 code E11.x)
2. HbA1c at or above 7.0% (some plans require 7.5% or 8.0%)
3. Documented trial of metformin at an adequate dose and duration (usually 90 days), unless metformin is contraindicated or not tolerated
4. Documentation that the prescriber is treating the patient for diabetes (not solely for weight loss)
5. For the cardiovascular risk reduction indication: documentation of established ASCVD or high CV risk per ADA/ACC criteria 5

Some plans add a step-therapy requirement: trial of one or two other diabetes agents (sulfonylurea, SGLT-2 inhibitor, or a preferred GLP-1) before Trulicity is approved. Step therapy waivers are available in most states when the prescriber documents clinical reasons why the step agent is not appropriate.

What Your Prescriber Should Submit

A PA for Trulicity that gets approved on the first submission almost always includes:

• Recent HbA1c lab value with date
• List of current and prior diabetes medications with start and stop dates
• Reason for choosing Trulicity over the preferred formulary agent (if applicable)
• Any contraindications or adverse effects from step-therapy drugs
• ICD-10 diagnosis code and, if applicable, documented cardiovascular disease codes

The REWIND trial (N=9,901 patients, median follow-up 5.4 years) demonstrated a statistically significant 12% relative risk reduction in major adverse cardiovascular events (MACE) with dulaglutide vs. Placebo (HR 0.88, 95% CI 0.79 to 0.99, P=0.026). 6 Citing this outcome data in the PA letter, alongside the ADA guideline preference for GLP-1 RAs in patients with ASCVD, strengthens the clinical rationale considerably.

PA Timelines

Anthem must respond to a standard PA within 3 business days under most state prompt-pay and utilization review laws. Urgent PAs (when a delay would harm the patient) must be resolved within 24 to 72 hours. If you have not received a decision within the statutory window, call Anthem provider services and document the call with date, time, and representative name.

What to Do When Anthem Denies Trulicity Coverage

Denial is not the end of the road. Roughly 40 to 60% of internal insurance appeals succeed when the patient or prescriber provides additional clinical documentation.

Step 1: Get the Denial in Writing

Anthem is required to send a written Explanation of Benefits (EOB) or denial letter explaining the specific reason for denial. Common denial reasons include:

• Step therapy not completed
• Missing documentation of HbA1c or prior drug trials
• Drug not on the plan's formulary
• PA not submitted before dispensing

Step 2: File an Internal Appeal

You have the right to appeal any adverse coverage decision. The timeline is typically 180 days from the denial notice for commercial plans under ERISA and ACA rules. Submit a letter of medical necessity from the prescriber, the relevant lab values, and guideline citations (ADA 2024 Standards of Care 7, ACC/AHA cardiovascular risk guidelines 8) alongside the appeal.

Step 3: Request an External Review

If the internal appeal is denied, you can request an independent external review through your state insurance commissioner's office or, for self-funded employer plans, through a federally contracted Independent Review Organization (IRO). External reviewers overturn denials in a meaningful proportion of cases, particularly for medications with strong guideline support.

Step 4: Pursue Alternative Access While Appealing

While an appeal is pending, patients can access Trulicity through:

• Lilly's Trulicity Savings Card: Eligible commercially insured patients may pay as low as $35, $150 per month. Savings cards are not valid for Medicare or Medicaid.
• Lilly Cares Foundation: The patient assistance program provides free Trulicity to qualifying uninsured or underinsured patients with household income below 400% of the federal poverty level. 9
• GoodRx and similar discount programs: GoodRx coupons for Trulicity have ranged from $650, $850 per month, which undercuts the list price but remains expensive for most patients.

Alternatives to Trulicity That Anthem May Cover at Lower Cost

If Trulicity is denied or placed on a prohibitively expensive tier, several alternative GLP-1 RAs and diabetes medications may be better positioned on your specific Anthem formulary.

Other GLP-1 Receptor Agonists

The SUSTAIN-6 trial (N=3,297) demonstrated that once-weekly semaglutide (Ozempic) reduced MACE by 26% vs. Placebo (HR 0.74, 95% CI 0.58 to 0.95, P<0.001 for non-inferiority). 10 Ozempic may be on a preferred tier where Trulicity is not, making a therapeutic substitution clinically reasonable and financially beneficial.

Victoza (liraglutide) showed a 13% MACE reduction in the LEADER trial (N=9,340, HR 0.87, 95% CI 0.78 to 0.97, P<0.001 for non-inferiority). 11 It requires daily injection rather than weekly, which some patients find less convenient, but it may carry lower cost-sharing on certain Anthem formularies.

SGLT-2 Inhibitors as Add-On or Alternative

For patients whose primary goal is cardiovascular or kidney protection, SGLT-2 inhibitors (empagliflozin, dapagliflozin, canagliflozin) have strong guideline support and often land on lower formulary tiers. The 2024 ADA Standards of Care give SGLT-2 inhibitors a Class A recommendation in patients with type 2 diabetes and heart failure or chronic kidney disease. 12

How to Check Your Specific Anthem Plan's Trulicity Coverage Today

Formularies change annually. The steps below take under 10 minutes.

Step 1: Use Anthem's Online Formulary Tool

Log into your Anthem member account at anthem.com, manage to "Pharmacy," then "Drug Cost and Coverage." Search for "dulaglutide" (the generic name) or "Trulicity." The tool will show your tier, estimated cost-share, and whether a PA is required. 13

Step 2: Call Anthem Pharmacy Benefits

The pharmacy benefits number is on the back of your member ID card. Ask specifically:

• "Is dulaglutide (Trulicity) on my formulary, and at what tier?"
• "Is a prior authorization required?"
• "Is there a step-therapy requirement before Trulicity is covered?"
• "What is my estimated cost-share after my deductible is met?"

Document the representative's name, the date, and the reference number they provide.

Step 3: Ask Your Pharmacy to Run a Test Claim

Before your prescriber submits the PA, ask your pharmacy to run a test claim for Trulicity. The pharmacy will see the real-time adjudication result, which shows the exact copay or whether a PA is needed. This takes two minutes and costs nothing.

The three-step verification framework above (online formulary check, phone confirmation, test claim) is the most reliable sequence for confirming real-time Trulicity coverage. Online formulary databases lag plan updates by up to 30 days, so the test claim at the pharmacy serves as the ground-truth check.

The Clinical Case for Trulicity: Why Prescribers Fight for Coverage

Understanding the clinical evidence helps patients advocate more confidently with their insurer. Trulicity is not a lifestyle drug. It is a medication with mortality-relevant outcome data.

Cardiovascular Outcomes

The REWIND trial enrolled 9,901 adults with type 2 diabetes aged 50 or older, with either established cardiovascular disease (31%) or cardiovascular risk factors (69%). Over a median 5.4 years, dulaglutide 1.5 mg weekly reduced the composite of nonfatal MI, nonfatal stroke, and CV death by 12% compared with placebo (HR 0.88, 95% CI 0.79 to 0.99). 14 REWIND is notable because it included a higher proportion of patients without established ASCVD than earlier GLP-1 outcome trials, broadening the population that may benefit.

Glycemic Efficacy

In the AWARD-5 trial (N=1,098), dulaglutide 1.5 mg weekly reduced HbA1c by 1.1 percentage points from a mean baseline of 8.1% at 52 weeks, compared with 0.4 percentage points for sitagliptin 100 mg. 15 The difference was statistically significant (P<0.001).

Weight and Renal Effects

In AWARD-11 (N=1,842), adding dulaglutide 4.5 mg (the higher dose, also FDA-approved) to insulin produced an additional 3.6 kg weight loss versus placebo over 36 weeks. 16 Separate analyses of REWIND showed dulaglutide slowed eGFR decline and reduced macroalbuminuria progression, findings consistent with GLP-1 class effects on the kidney. 17

The American Association of Clinical Endocrinology 2022 consensus states: "GLP-1 receptor agonists with proven cardiovascular benefit should be prioritized in patients with type 2 diabetes and established or high-risk ASCVD, regardless of baseline HbA1c." 18 That consensus language is directly usable in a PA letter or appeal.

Cost-Reduction Strategies While Coverage Is Pending

Even with approved PA, out-of-pocket costs can feel steep in deductible-heavy plans. Several strategies can reduce net cost.

Lilly's Savings Programs

Eli Lilly offers the Trulicity Savings Card for commercially insured patients. Eligible patients may pay as little as $35 per month for a 90-day supply, with a maximum savings cap per year (confirm current terms at lilly.com, as caps update annually). This card cannot be used alongside Medicare or Medicaid coverage. 19

Health Savings Accounts and Flexible Spending Accounts

Trulicity purchases count as qualified medical expenses under IRS rules, making HSA and FSA funds applicable. Patients on high-deductible health plans (HDHPs) paired with an HSA can use pre-tax dollars, effectively reducing the after-tax cost by their marginal tax rate (22 to 32% for many working adults).

90-Day Supply vs. 30-Day Supply

Many Anthem plans apply a lower copay or waive a dispensing fee when filling a 90-day supply through mail-order pharmacy (Anthem's IngenioRx). The per-unit cost-share is often 10 to 20% lower than three separate 30-day fills at a retail pharmacy.